475 related articles for article (PubMed ID: 20590498)
1. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
Giguère S; Lee E; Williams E; Cohen ND; Chaffin MK; Halbert N; Martens RJ; Franklin RP; Clark CC; Slovis NM
J Am Vet Med Assoc; 2010 Jul; 237(1):74-81. PubMed ID: 20590498
[TBL] [Abstract][Full Text] [Related]
2. Chemoprophylactic effects of azithromycin against Rhodococcus equi-induced pneumonia among foals at equine breeding farms with endemic infections.
Chaffin MK; Cohen ND; Martens RJ
J Am Vet Med Assoc; 2008 Apr; 232(7):1035-47. PubMed ID: 18380623
[TBL] [Abstract][Full Text] [Related]
3. Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
Huber L; Giguère S; Slovis NM; Carter CN; Barr BS; Cohen ND; Elam J; Erol E; Locke SJ; Phillips ED; Smith JL
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373803
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Infections Caused by Rhodococcus equi.
Giguère S
Vet Clin North Am Equine Pract; 2017 Apr; 33(1):67-85. PubMed ID: 28161038
[TBL] [Abstract][Full Text] [Related]
5. Effect of Macrolide and Rifampin Resistance on the Fitness of Rhodococcus equi.
Willingham-Lane JM; Berghaus LJ; Berghaus RD; Hart KA; Giguère S
Appl Environ Microbiol; 2019 Apr; 85(7):. PubMed ID: 30683740
[No Abstract] [Full Text] [Related]
6. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
Berghaus LJ; Giguère S; Guldbech K
Vet Microbiol; 2013 Oct; 166(3-4):670-5. PubMed ID: 23915992
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility patterns of Rhodococcus equi from necropsied foals with rhodococcosis.
Erol E; Locke S; Saied A; Cruz Penn MJ; Smith J; Fortner J; Carter C
Vet Microbiol; 2020 Mar; 242():108568. PubMed ID: 32122582
[TBL] [Abstract][Full Text] [Related]
8. Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
Boyen F; Pasmans F; Haesebrouck F
Vet Rec; 2011 Jan; 168(4):101a. PubMed ID: 21257598
[No Abstract] [Full Text] [Related]
9. Gallium maltolate as an alternative to macrolides for treatment of presumed Rhodococcus equi pneumonia in foals.
Cohen ND; Slovis NM; Giguère S; Baker S; Chaffin MK; Bernstein LR
J Vet Intern Med; 2015; 29(3):932-9. PubMed ID: 25868480
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Resistance in
Giguère S; Berghaus LJ; Willingham-Lane JM
Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052538
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and therapy of Rhodococcus equi infection in the horse].
Boswinkel M; Sloet van Oldruitenborgh-Oosterbaan MM
Tijdschr Diergeneeskd; 2006 Sep; 131(17):602-11. PubMed ID: 16989420
[TBL] [Abstract][Full Text] [Related]
12. Effect of Macrolide and Rifampin Resistance on Fitness of
Willingham-Lane JM; Berghaus LJ; Berghaus RD; Hart KA; Giguère S
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331959
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals.
Fines M; Pronost S; Maillard K; Taouji S; Leclercq R
J Clin Microbiol; 2001 Aug; 39(8):2784-7. PubMed ID: 11473992
[TBL] [Abstract][Full Text] [Related]
14. Identification of macrolide- and rifampicin-resistant Rhodococcus equi in environmental samples from equine breeding farms in central Kentucky during 2018.
Huber L; Giguère S; Cohen ND; Slovis NM; Berghaus L; Greiter M; Hart KA
Vet Microbiol; 2019 May; 232():74-78. PubMed ID: 31030848
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of virulent Rhodococcus equi in isolates from soil collected from two horse farms in South Africa and restriction fragment length polymorphisms of virulence plasmids in the isolates from infected foals, a dog and a monkey.
Takai S; Henton MM; Picard JA; Guthrie AJ; Fukushi H; Sugimoto C
Onderstepoort J Vet Res; 2001 Jun; 68(2):105-10. PubMed ID: 11585087
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi.
Giguère S; Lee EA; Guldbech KM; Berghaus LJ
Vet Microbiol; 2012 Nov; 160(1-2):207-13. PubMed ID: 22704561
[TBL] [Abstract][Full Text] [Related]
17. Association of soil concentrations of Rhodococcus equi and incidence of pneumonia attributable to Rhodococcus equi in foals on farms in central Kentucky.
Cohen ND; Carter CN; Scott HM; Chaffin MK; Smith JL; Grimm MB; Kuskie KR; Takai S; Martens RJ
Am J Vet Res; 2008 Mar; 69(3):385-95. PubMed ID: 18312138
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors associated with emergence of Rhodococcus equi resistance to macrolides and rifampicin in horse-breeding farms in Kentucky, USA.
Huber L; Giguère S; Cohen ND; Slovis NM; Hanafi A; Schuckert A; Berghaus L; Greiter M; Hart KA
Vet Microbiol; 2019 Aug; 235():243-247. PubMed ID: 31383308
[TBL] [Abstract][Full Text] [Related]
19. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia.
Giguère S; Jacks S; Roberts GD; Hernandez J; Long MT; Ellis C
J Vet Intern Med; 2004; 18(4):568-73. PubMed ID: 15320600
[TBL] [Abstract][Full Text] [Related]
20. Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi.
Anastasi E; Giguère S; Berghaus LJ; Hondalus MK; Willingham-Lane JM; MacArthur I; Cohen ND; Roberts MC; Vazquez-Boland JA
J Antimicrob Chemother; 2015 Dec; 70(12):3184-90. PubMed ID: 26377866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
